Tag:

Hepatitis

Dynavax soars as Sanofi announces $2.2B acquisition

Sanofi (SNY) will acquire U.S. vaccine maker Dynavax Technologies (DVAX) for approximately $2.2 billion (1.9 billion euros), the French pharmaceutical company announced Wednesday.

24 Dec 2025-16:12
US scrutinizes Hepatitis B vaccine for newborns

04 Dec 2025-22:29
Czech Republic reports sharp rise in hepatitis A cases

11 Aug 2025-23:03
Around 250 cases of hepatitis of unknown origin registered worldwide: WHO

18 May 2022-05:09
Romania reports first case of acute hepatitis of unknown origin

26 Apr 2022-06:34

Prev Next